Ask HN: What good sources of information on ovarian cancer treatments?

Ask HN: What good sources of information on ovarian cancer treatments?

25 points by cebert 9 hours ago | hide | past | favorite | 15 comments

I don’t have a great deal of medical knowledge. My mother was diagnosed with ovarian cancer, and I would like to see if anyone here knows of good sources of information.

My mother had a full hysterectomy this week and the medical team believes they were able to remove all visible signs of cancer. Following recovery, she’ll likely start chemotherapy to help kill off any remaining cancer.

Publications like pubmed are generally a good source to read from, check the citations on the article & check its review status.

If you have an article that you found with a helpful summary but it doesn’t have the full source, take the “doi” link to sci-hub to get the full source.

Try to stay away from any article on any site that doesn’t have a research article referenced that has a doi number.

Do checkout discussion around the endocannabinoid system in relation to recovery & chemotherapy support.

When you get the details on the specific chemotherapy being done, you’ll have a specific couple of chemicals to be able to search through… for example Gemcitabine and Carboplatin. Different kinds of cancers have a different sets of chemotherapy chemicals related.

I’ll mention that I have a close family member with terminal lung cancer. Following the above we’ve been successfully treating his symptoms and have also reduced the size of the primary tumour along the way (It was non operable & no radiation could be done)

Hey OP, in case you have a hardtime trying to download these articles from Pubmed, feel free to reach me nothingcomeseasy [at] protonmail [dot] com and I see if I can help. Wishing all the best to your mom!

Early diagnosis is key with ovarian cancer, so it sound like your mother was lucky to have had it caught in time.

You might consider asking her oncologist if they intend to use PARP inhibitors post chemo to help keep the cancer in remission. There are currently several promising clinical trials ongoing for immunotherapy protocols for ovarian cancer, so the goal would be to keep the cancer in remission until those are generally available.

Wishing the best, take care.

(Not a medical practitioner, bring questions and information to your mother’s doctors, and do not feel intimidated to ask questions based on your research)

Firstly, I am sorry to read that.

Secondly, if they removed all visible signs, that is great and very hopeful.

If my loved one had a serious medical condition, and there wasn’t a known cure — for instance if it comes back — I would look at the government database that lists current trials in the U.S. (assuming you live in the U.S) and then I would research each potential treatment in turn.

As fabiancook mentions, credible sources all end up on pubmed within a year or two of publication, so it’s an excellent resource.

That said, Pubmed is an aggregator, not a curator. So you’ll find a fair amount of crap there too. Also, there are ~600 results per year related to ovarian cancer, which is likely too much to meaningfully sift through.

The things that come to mind for me are:

– Try to get second, third, fourth opinions from well regarded oncologists at well regarded hospitals, ideally who specialize in ovarian cancer. There is a pretty big gap, especially in cancer treatment, between those who keep up with the latest recommendations, and those who use “still ok” recommendations from 5-10-20-30 years ago

– ASCO is the major scientific conference for oncologists. In terms of understanding what is cutting edge, looking through their material is useful. I would suggest reading what has been presented at ASCO and then taking that to your doctors / second opinions.

– If there are specific biomarkers associated with her cancer, understand those, and make sure you understand if there are latest recommendations specific to those biomarkers. These are the types of specific case information that a generalist oncologist might miss (e.g. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998656/)

– Another place you might be able to complement / compensate your oncologist’s care is understanding options for “cancer support” (chemotherapy support as fabian says). Basically, the faster you can recover between treatment sessions, the more drug you can be given faster, and the more cancer gets killed. Oncologists are often (but not always) more up to date with the latest chemo/immuno/surgery/radiological interventions than with the options for chemo support.

Gold standard we use in oncology are the National comprehensive Cancer Network – https://nccn.org
There are guidelines for almost all malignancies and their standard methods of treatment. They are very detailed. They outline (many flowcharts) what to do on the second, third and sometimes 4th recurrence of malignancy.

You need to register for an account to view them, but it is still free I believe. You’ll find out more than you would want to know there

I worked in the biotech space and this – NCCN (US) or ESMO (EU) guidelines are the place to start. Unless you’re a very unique case, most doctors won’t even consider cutting edge therapies until you’ve failed at least one of the more common treatments.

Sign up for a free account and download the guidelines. They are evidence driven and give you a sense of what the current standard of treatment is and how strong the evidence is. Not sure about ESMO, but NCCN even publishes a patient-friendly version now.

If guidelines treatments fail (which would likely take a while as there are multiple lines of therapy) then you’re getting into the clinical trial space and you’d likely need to get input from someone in academics who is close to the space and does research. But major hospitals usually have “tumor boards” where the oncologists get together and go through challenging patient cases and make recommendations on next steps. But sounds like OP is nowhere close to that.

* Look into recent academic reviews and the literature they cite as a good entry point: https://scholar.google.com/scholar?as_ylo=2019&q=ovarian+can…

* If you have sufficient funds, consider measuring circulating tumor DNA to ensure she has low numbers of cancer cells.

* If she gets into remission, sequence the tissue they extracted in the hysterectomy (DNA & RNA) and hopefully preserved in FFPE. Use to see the type of tumor.

My mother had some type of stomach cancer and got her stomach removed, and then she had chemo. She received a fairly modern drug (Rituximab), and I think this is probably what saved her life. This was 10 years ago, and she is doing fine right now, without any signs of remission.

In your case, the doctors will prescribe the best course of action. The chemo drugs are different, but you can expect 2 things: chemo will be rough, and her immune system will be weak.

One thing you should consider to prepare for the weakened immune system is vaccination. I for one am very pro-vaxx, but you should do your research. If I were in this position, I’d advise my Mom to get the latest Covid booster, and the flu shot. I’d look into pneumonia and shingles vaccines too.

My Mom got a herpes infection when she was doing chemo. That’s not fun. Later on, she got shingles. This was years after the chemo, but it took maybe half a year to clear out. Things that are easy on a healthy person can become major nuisances for someone with chemo.

Great suggestion on getting an additional COVID booster. I’ll bring it up with her medical providers.

Maybe check out MD Anderson Cancer Center? I don’t have any specific knowledge of their educational materials, but they are one of the leaders in oncology in the US.

Read More
Johnathon Volkman

Latest

Oregon Sues Oklahoma Transfer Over Alleged Unpaid $10K NIL Contract Buyout

The University of Oregon says one of its former football players owes it $10,000, and the school is willing to go to court to get it. The school filed a lawsuit in Lane County Circuit Court last week against Dakoda Fields, a defensive back who spent two years with the Ducks before transferring to Oklahoma

Breaking Down Ole Miss’ Strengths, Weaknesses and One Thing It Needs to Beat LSU

The hottest location in college football this year brings LSU and Ole Miss together for a matchup that should be as close are expected. Both teams are rebuilt through the transfer portal and new coaching staffs, and this Sept. 19 matchup will be the first big test for either squad. So what gives Ole Miss

What are Indiana Football’s Biggest Trap Games of 2026?

Where will Indiana be ranked to start the 2026 college football season? While debate will rage regardless of the number next to Indiana's name to start the year, the Hoosiers will likely be favored in no fewer than 11 of their 12 regular season contests. That doesn't mean there won't be challenges along the way

Green steel startup Boston Metal is doubling down on critical metals

The startup Boston Metal has raised a $75 million funding round to produce critical metals, MIT Technology Review can exclusively report.   The company has been known largely for its efforts to clean up steel production, an industry that's responsible for about 8% of global greenhouse emissions today. With the additional money, the new focus could

Newsletter

Don't miss

Oregon Sues Oklahoma Transfer Over Alleged Unpaid $10K NIL Contract Buyout

The University of Oregon says one of its former football players owes it $10,000, and the school is willing to go to court to get it. The school filed a lawsuit in Lane County Circuit Court last week against Dakoda Fields, a defensive back who spent two years with the Ducks before transferring to Oklahoma

Breaking Down Ole Miss’ Strengths, Weaknesses and One Thing It Needs to Beat LSU

The hottest location in college football this year brings LSU and Ole Miss together for a matchup that should be as close are expected. Both teams are rebuilt through the transfer portal and new coaching staffs, and this Sept. 19 matchup will be the first big test for either squad. So what gives Ole Miss

What are Indiana Football’s Biggest Trap Games of 2026?

Where will Indiana be ranked to start the 2026 college football season? While debate will rage regardless of the number next to Indiana's name to start the year, the Hoosiers will likely be favored in no fewer than 11 of their 12 regular season contests. That doesn't mean there won't be challenges along the way

Green steel startup Boston Metal is doubling down on critical metals

The startup Boston Metal has raised a $75 million funding round to produce critical metals, MIT Technology Review can exclusively report.   The company has been known largely for its efforts to clean up steel production, an industry that's responsible for about 8% of global greenhouse emissions today. With the additional money, the new focus could

Embracer Follows Ubisoft In Splitting Off New Publisher To Handle Huge IP, Tomb Raider & LOTR Included

Say hello to Fellowship Entertainment by Ben Kerry 11 hours ago Embracer Group has today announced plans to create a secondary publishing label called Fellowship Entertainment, in order to "capture the full potential of the high-quality assets" that the group currently owns. The Swedish game publisher says that it hopes to spin off Fellowship Entertainment

Tesla’s Business Has Become Much More Diversified in Just the Past Five Years. Does That Make Its Stock a Better Buy Today?

Key Points Tesla's energy generation and storage segment generated 27% revenue growth last year. The company's non-automotive segments were able to help offset a double-digit decline in auto revenue in 2025. These 10 stocks could mint the next wave of millionaires › Tesla (NASDAQ: TSLA) is known for its electric vehicles (EVs), and while they

WD sees sustainability as key business driver in an ‘AI economy’

Hard drive company WD promoted long-term operations and sustainability executive Jackie Jung to become its first chief sustainability officer in February, as it steps up sales to companies building AI data centers. Her vision: Turn sustainability into a “brand” for WD, a strategy that reduces risk for the $6 billion company (formerly known as Western

5 Business Ideas Worth Starting in 2026

If there is one thing Nigerians understand well, it is how to spot opportunity inside hardship. In 2026, that mindset will matter more than ever. The economy is tough, competition is rising, and many people are looking for smarter ways to earn, build, and survive. But even in a difficult environment, some businesses still stand